Skip to content
Riskpilot
← Back to search
Sign in
Get full access
INSULIFE AS
AS
Active
Org 925128554
Gaustadalléen 21, 0349
Oslo
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2020 · 6 years old
5 employees
www.insulife.com
Monitor
Share
Norway
/
Companies
/
Manufacture of pharmaceutical preparations
/
INSULIFE AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
ÅN
Åge Nærdal
Chief Executive Officer
Chief Executive Officer
2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (7)
PH
Per Heiberg Dybwad
Deputy Chairman
Deputy Chairman
2024
BE
Bjørg Eikeland
Board of Directors
Board of Directors
2024
PW
Petter Wessel Bjornstad
Chairman
Chairman
2022
PE
Pål Eriksen
Board of Directors
Board of Directors
2022
AW
Anne Waaler
Board of Directors
Board of Directors
2022
DW
David Weild Iv
Board of Directors
Board of Directors
2024
GD
Gregory David Cash
Board of Directors
Board of Directors
2024
Former (5)
EC
Eric Cameron
Chairman
Chairman
2022 – 2022
RV
Rolf Viggo Leisner
Board of Directors
Board of Directors
2022 – 2022
KS
Kari Struksnes
Board of Directors
Board of Directors
2022 – 2024
KB
Kenneth Bruce Kirby
Board of Directors
Board of Directors
2022 – 2024
BJ
Bert Joseph Moerings
Board of Directors
Board of Directors
2022 – 2022
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Wessel Capital Llc
Company
23.46%
23.46%
2025
Transdermal Delivery Solutions Cor
Company
22.13%
22.13%
2025
Pharmamentor As
Company
8.48%
8.48%
2025
Siro Clinpharm Private Limited
Company
3.52%
3.52%
2025
Scanpipe Engineering As
Company
3.29%
3.29%
2025
Silvercoin Industries As
Company
2.79%
2.79%
2025
Skadi As
Company
2.74%
2.74%
2025
3t Holding As
Company
2.2%
2.2%
2025
Smerud Medical Research International As
Company
1.7%
1.7%
2025
Christian Henrik Theiste
Individual
1.4%
1.4%
2025
Konstrukt Holding As
Company
1.21%
1.21%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on INSULIFE AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network